Preparation of monomer of degradable biomaterial poly（L-lactide）

1INTRODUCTION Polylactide,oneoftheimportantbiodegrada blematerials,whichhasfavorablebiocompatibility andabsorption[1],hasbeenusedinimplant,chor dasericachirurgicalis,drugcontrolledrelease,boneinternalfixation,tissueengineeringetc[25]. Thepoly(L lactide)(PLLA)withhighrelative molecularmasswasobtainedbyring openingpoly merizationatpresent.Thatis,firsttheintermedi ateproduct(lactide)wasobtainedfromlacticacid, thenthepoly(L lactide)wasobtainedfrominter mediateproductbyring openingpolymer…     

Physical and thermal properties of l‐lactide/ϵ‐caprolactone copolymers: the role of microstructural design

Understanding the underlying role of microstructural design in polymers allows for the manipulation and control of properties for a wide range of specific applications. As such, this work focuses on the study of microstructure–property relationships in l‐ lactide/?‐caprolactone (LL/CL) copolymers. One‐step and two‐step bulk ring‐opening polymerization (ROP) procedures were employed to synthesize LL/CL copolymers of various compositions and chain microstructures. In the one‐step procedure, LL and CL were simultaneously copolymerized to yield P(LL‐stat‐CL) statistical copolymers. In the two‐step procedure, poly(l‐ lactide) (PLL) and poly(?‐caprolactone) (PCL) prepolymers were synthesized in the first step before CL and LL respectively were added in the second step to yield P[LL‐b‐(CL‐stat‐LL)‐b‐LL] and P[CL‐b‐(LL‐stat‐CL)‐b‐CL] block copolymers as the final products. The findings reveal that, in addition to the copolymerization procedure employed, the length and type of the prepolymer play important roles in determining the chain microstructure and thereby the overall properties of the final copolymer. Moreover, control over the degree of crystallinity and the type of crystalline domains, which is controlled during the polymer chemistry process, heavily influences the physical and mechanical properties of the final polymer. In summary, this work describes an interesting approach to the microstructural design of biodegradable copolymers of LL and CL for potential use in biomedical applications. © 2019 Society of Chemical Industry     

Synthesis and characterisation of fluorescent pyrene‐end‐capped polylactide fibres

Fluorescent markers are critical for tracking the position and movement of molecules both in vivo and in vitro. Conventionally, synthetic dyes are non‐covalently added to polymers for fluorescent tracking, but often diffuse away. Here we demonstrate, for the first time, a facile method for the synthesis of fluorescent poly(lactic acid) nano‐/microfibres for biomedical applications using solution spin blowing. Pyrene‐end‐capped poly(l ‐lactide) (PLLA) derivatives were synthesised using the ring‐opening polymerisation of l ‐lactide and they were characterised using spectroscopic and thermal analyses. Submicrometre‐sized fluorescent fibres were produced from these PLLA derivatives using solution blow spinning techniques generating polymer blends and core–shell fibres. Such system could be further exploited to incorporate electrically conductive carbon allotropes via the pyrene aromaticity, producing fluorescent and electrically active fibres for in vitro monitoring and electrical stimulation. © 2018 Society of Chemical Industry     

含PLA-PEG-PLA三嵌段共聚物的 可降解聚氨酯的合成及表征

用聚乙二醇（PEG）和左旋丙交酯（L－LA）合成了不同比例的聚乳酸－聚乙二醇三嵌段共聚物（PLA-PEG-PLA）,通过傅立叶变换红外光谱分析（FTIR）和核磁共振(1H NMR)测试分析了所得嵌段共聚物的结构。并以此嵌段共聚物为软段,用溶液法和六亚甲基二异氰酸酯（HDI）和扩链剂（BDO）以不同的比例合成了一系列聚氨酯,通过傅立叶变换红外光谱分析（FTIR）和差动量热扫描分析（DSC）表征聚氨酯结构。对此聚氨酯在37 ℃的PBS缓冲溶液（pH＝7.4）中进行模拟体内环境的降解测试,通过失重率来评价聚氨酯的降解速率,结果表明降解速度与软硬段比例,共聚物中PEG/PLA的比例有关。并且实验表明此材料不会引起红细胞发生溶血。因此这种新型可降解聚氨酯材料可以根据各组分以及组分比例来调整聚合物的降解速率,此材料将在组织工程支架以及药物缓释载体领域有广阔的应用前景。     

磷钨酸-氧化锌催化合成D,L-丙交酯

采用磷钨酸-氧化锌为催化剂,将D,L-乳酸先缩聚后解聚制备了D,L-丙交酯。研究表明:在以催化剂质量分数为乳酸的1.2%,磷钨酸(H3PW12O14)与ZnO质量比2/3,真空度为2.0 kPa,缩聚时间为2.5 h,缩聚温度为140℃,解聚温度为230℃的条件下,用乙酸乙酯重结晶之后,可获得的D,L-丙交酯产率为25.0%。在同等条件下,加入10 mL乙二醇作为稀释剂,用乙酸乙酯重结晶之后可获得的D,L-丙交酯产率为29.4%。     

Preparation of poly(ε‐caprolactone)/poly(ε‐caprolactone‐co‐lactide) (PCL/PLCL) blend filament by melt spinning

Poly(ε‐caprolactone)/poly(ε‐caprolactone‐co‐lactide) (PCL/PLCL) blend filaments with various ratios of PCL and PLCL were prepared by melt spinning. The effect of PLCL content on the physical properties of the blended filament was investigated. The melt spinning of the blend was carried out and the as spun filament was subsequently subjected to drawing and heat setting process. The addition of PLCL caused significant changes in the mechanical properties of the filaments. Crystallinity of blend decreased with the addition of PLCL as observed by X‐ray diffraction (XRD) and differential scanning calorimetry (DSC). Scanning electron microscopy (SEM) revealed that the fracture surface becomes rougher at higher PLCL content. It may be proposed that PCL and PLCL show limited interaction within the blend matrix. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012     

Poly(N‐isopropylacrylamide‐co‐hydroxyethyl methacrylate) graft copolymers and their application as carriers for drug delivery system

Poly(N‐isopropylacrylamide‐co‐hydroxyethyl methacrylate) [P(NIPAM‐co‐HEMA)] copolymer was synthesized by controlled radical polymerization from respective N‐isopropylacrylamide (NIPAM) and hydroxyethyl methacrylate (HEMA) monomers with a predetermined ratio. To prepare the thermosensitive and biodegradable nanoparticles, new thermosensitive graft copolymer, poly(L ‐lactide)‐graft‐poly(N‐isoporylacrylamide‐co‐hydroxyethyl methacrylate) [PLLA‐g‐P(NIPAM‐co‐HEMA)], with the lower critical solution temperature (LCST) near the normal body temperature, was synthesized by ring opening polymerization of L ‐lactide in the presence of P(NIPAM‐co‐HEMA). The amphiphilic property of the graft copolymers was formed by the grafting of the PLLA hydrophobic chains onto the PNIPAM based hydrophilic backbone. Therefore, the graft copolymers can self‐assemble into uniformly spherical micelles ò about 150–240 nm in diameter as observed by the field emission scanning electron microscope and dynamic light scattering. Dexamethasone can be loaded into these nanostructures during dialysis with a relative high loading capacity and its in vitro release depends on temperature. Above the LCST, most of the drugs were released from the drug‐loaded micelles, whereas a large amount of drugs still remains in the micelles after 48 h below the LCST. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012     

Effect of nucleation mechanism on complex poly(L‐lactide) nonisothermal crystallization process,part 2: Crystallization kinetics analysis

In the first part of this article, we reported the crystalline memory effect on the nonisothermal crystallization of poly(L ‐lactide). The experiments were carried out by using polymer single crystals growth from dilute solution as standard starting material. In this article (Part II), we have analyzed in detail the effect of the melting condition on the overall crystallization kinetics by applying the Nakamura‐Avrami model to DSC results. The absence or the low concentration of foreign infusible heterogeneous nuclei in our system allowed us to exalt the self‐nuclei role in polymer crystallization, to follow their concentration decrease during the melting process and to find the limiting melting temperature for their disappearance. Below such a temperature, a stable equilibrium number of self‐nuclei was observed, probably deriving from ordered structures, persisting in the melt, and originated from the single crystals thickening process during the polymer dynamic melting in the DSC. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012     

Morphological study on thermal treatment and degradation behaviors of solution-grown poly(l-lactide) single crystals

Morphological changes of solution-grown crystals (SGCs) of poly(l-lactide) (PLLA) following thermal treatment and enzymatic degradation were investigated using atomic force microscopy in terms of defects in the crystals. PLLA SGCs were grown from a dilute solution of acetonitrile at 5 °C. The obtained solution-grown monolamellar crystals have a lozenge-shaped morphology containing unique dimensions, with one side measuring 12 μm. To investigate enzymatic degradation behavior, PLLA SGCs were incubated in buffered solution with proteinase-K at 37 °C. The initial stage of enzymatic degradation of PLLA SGCs with proteinase-K occurs in loosely folding chains at the surface of the crystal. Thermally treated PLLA SGCs below the melting temperature showed an increase of the lamellar thickness of the SGCs at the treated temperature and partial surface erosion following enzyme exposure. These results indicate that less ordered chains exist throughout the lamellae and their thermal-induced chain extension makes them more susceptible to enzyme attack.     

Development and Comprehensive Characteristics of Thermosensitive Liquid Suppositories of Metoprolol Based on Poly(lactide-co-glycolide) Nanoparticles

Thermosensitive liquid suppositories (LSs) carrying the model antihypertensive drug metoprolol tartrate (MT) were developed and evaluated. The fundamental purpose of this work was to produce, for the first time, liquid MT suppositories based on biodegradable nanoparticles and optimize their rheological and mechanical properties for prospective rectal administration. The nanoparticle system was based on a biodegradable copolymer synthesized by ring opening polymerization (ROP) of glycolide (GL) and L,L-lactide (LLA). Biodegradable nanoparticles loaded with the model drug were produced by the o/o method at the first stage of the investigation. Depending on the concentration of the drug in the sample, from 66 to 91% of MT was released over 12 h, according to first-order kinetics. Then, thermosensitive LSs with MT-loaded biodegradable nanoparticles were obtained by a cold method and their mechanical and rheological properties were evaluated. To adjust the thermogelling and mucoadhesive properties for rectal administration, the amounts of major formulation components such as poloxamers (P407, P188), Tween 80, hydroxypropylcellulose (HPC), polyvinylpyrrolidone (PVP), and sodium alginate were optimized. The in vitro release results revealed that more than 80% of the MT was released after 12 h, following also first-order kinetics. It was discovered that the diffusion process was dominant. The drug release profile was mainly governed by the rheological and mechanical properties of the developed formulation. Such a novel, thermosensitive formulation might be an effective alternative to hypertension treatment, particularly for unconscious patients, patients with mental illnesses, geriatric patients, and children.